AU1059095A - Treatment of viral disease with cd40l peptide - Google Patents

Treatment of viral disease with cd40l peptide

Info

Publication number: AU1059095A
Authority: AU; Australia
Prior art keywords: treatment; viral disease; cd40l peptide; cd40l; peptide
Prior art date: 1993-11-24
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU10590/95A

Inventor

Ian Allister Ramshaw

Janet Caroline Ruby

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Australian National University

Original Assignee

Australian National University

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-11-24

Filing date

1994-11-23

Publication date

1995-06-13

1994-11-23 Application filed by Australian National University filed Critical Australian National University

1995-06-13 Publication of AU1059095A publication Critical patent/AU1059095A/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Gastroenterology & Hepatology (AREA)
Toxicology (AREA)
Immunology (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Zoology (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Cell Biology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AU10590/95A 1993-11-24 1994-11-23 Treatment of viral disease with cd40l peptide Abandoned AU1059095A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
AUPM258793		1993-11-24
PCT/AU1994/000722 WO1995014487A1 (en)	1993-11-24	1994-11-23	Treatment of viral disease with cd40l peptide

Publications (1)

Publication Number	Publication Date
AU1059095A true AU1059095A (en)	1995-06-13

Family

ID=3777378

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU10590/95A Abandoned AU1059095A (en)	1993-11-24	1994-11-23	Treatment of viral disease with cd40l peptide

Country Status (2)

Country	Link
AU (1)	AU1059095A (en)
WO (1)	WO1995014487A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7070771B1 (en) *	1996-12-09	2006-07-04	Regents Of The University Of California	Methods of expressing chimeric mouse and human CD40 ligand in human CD40+ cells
AU781104B2 (en) *	1996-12-09	2005-05-05	Regents Of The University Of California, The	Novel expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease
EP1059932A1 (en) *	1997-12-19	2000-12-20	Immunex Corporation	Method for reducing susceptibility to hiv infection
CA2322160C (en) *	1998-02-27	2013-01-29	The Trustees Of The University Of Pennsylvania	Vaccines, immunotherapeutics and methods for using the same
US7786282B2 (en)	2001-12-06	2010-08-31	The Regents Of The University Of California	Nucleic acid molecules encoding TNF-α ligand polypeptides having a CD154 domain
US7495090B2 (en)	2002-05-23	2009-02-24	The Regents Of The University Of California	Nucleic acids encoding chimeric CD154 polypeptides
KR101460551B1 (en)	2006-09-18	2014-11-18	더 보드 오브 트러스티스 오브 더 유니버시티 오브 아칸소	Compositions and methods for improving immune response
BRPI0818736A2 (en)	2007-10-30	2017-06-13	Univ Arkansas	compositions and methods for enhancing immunoresponders to flagellated bacteria
PT2214701T (en)	2007-11-01	2016-11-02	Univ Guelph	Compositions and methods of enhancing immune responses to eimeria
AU2011207331C1 (en)	2010-01-21	2016-05-12	The Texas A&M University System	Vaccine vectors and methods of enhancing immune responses
EP3556397A1 (en)	2010-06-09	2019-10-23	The Board of Trustees of the University of Arkansas	Vaccine and methods to reduce campylobacter infection
SG11201506398SA (en)	2013-02-14	2015-09-29	Univ Arkansas	Compositions and methods of enhancing immune responses to eimeria or limiting eimeria infection
BR112015023024B1 (en)	2013-03-15	2022-04-19	The Board Of Trustees Of The University Of Arkansas	Vaccine vector and pharmaceutical compositions comprising the same
MX2018013331A (en)	2016-05-03	2019-06-10	Univ Arkansas	Yeast vaccine vector including immunostimulatory and antigenic polypeptides and methods of using the same.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69233402T3 (en) *	1991-10-25	2009-06-25	Immunex Corp., Seattle	NEW CYTOKINE
IL104684A0 (en) *	1992-02-14	1993-06-10	Bristol Myers Squibb Co	The cd40cr receptor and ligands therefor
DE4322330A1 (en) *	1992-08-31	1994-03-03	Behringwerke Ag	Use of the IL-4 receptor for the therapy, prophylaxis and diagnosis of allergic, viral, parasitic and bacterial diseases as well as fungal infections
WO1994004570A1 (en) *	1992-08-21	1994-03-03	Schering Corporation	Cd40 ligand, anti cd40 antibodies, and soluble cd40
US5540926A (en) *	1992-09-04	1996-07-30	Bristol-Myers Squibb Company	Soluble and its use in B cell stimulation

1994
- 1994-11-23 AU AU10590/95A patent/AU1059095A/en not_active Abandoned
- 1994-11-23 WO PCT/AU1994/000722 patent/WO1995014487A1/en active Application Filing

Also Published As

Publication number	Publication date
WO1995014487A1 (en)	1995-06-01

Publication	Publication Date	Title
AU6360394A (en)	1994-09-26	Vasonatrin peptide and analogs thereof
AU7043394A (en)	1994-12-20	Association peptides
AU7867994A (en)	1995-03-21	Hemofiltration of mediator-related diseases
AU3688393A (en)	1993-10-21	Surgical fastener
AU7516694A (en)	1995-02-28	Biotinylation of proteins
AU4230196A (en)	1996-06-06	Treatment of pancreatic tumors with peptide yy and analogs thereof
AU3802493A (en)	1993-09-13	Surgical endoclip
AU4944093A (en)	1994-04-12	Osteosynthesis aid
AU4514193A (en)	1994-01-31	Bone formation-inducing protein
AU4048295A (en)	1996-04-04	Peptide medicaments for the treatment of disease
AU1059095A (en)	1995-06-13	Treatment of viral disease with cd40l peptide
AU5681094A (en)	1994-06-22	Protein hydrolysate derived from mucosal tissue
AU4463996A (en)	1996-06-19	Ultraselective opioidmimetic peptides and pharmacological and therapeutic uses thereof
AU6774294A (en)	1994-11-21	Methods of preventing viral replication
AU3414689A (en)	1989-10-16	Therapeutic peptides
AU5380194A (en)	1994-08-18	Dual fixation prosthesis
AU6428890A (en)	1991-04-18	Therapeutic peptides and proteins
AU4775693A (en)	1994-02-14	Peptide medicaments for treating disease
AU5758594A (en)	1994-09-15	Treatment of viral infections
AU1192892A (en)	1993-08-03	Pharmaceutical preparation of antistress, stress-preventive and nootropic action
AU4628993A (en)	1994-03-17	Physiologically active peptide composition
AU6856194A (en)	1995-01-03	Vaginal preparation containing physiologically active peptide
AU1435695A (en)	1995-07-10	Recombinant human thymopoietin proteins and uses therefor
AU3187893A (en)	1993-07-29	Disposable internal electrode
AU6715094A (en)	1994-11-21	Recombinant vaccine